BIOMAT Database Logo BIOMAT Database Logo

[Long-term therapy with labetalol in medium and high grade arterial hypertension]. 1980

G Danti, and S Pomari, and G Covi, and E Pedrolli, and G Zannini, and M Mattioli, and A Lechi

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007741 Labetalol A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS. AH-5158,Albetol,Apo-Labetalol,Dilevalol,Labetalol Hydrochloride,Labetalol, (R,R)-Isomer,Labetolol,Normodyne,Presolol,R,R-Labetalol,SCH-19927,Trandate,AH 5158,AH5158,Apo Labetalol,ApoLabetalol,Hydrochloride, Labetalol,R,R Labetalol,SCH 19927,SCH19927
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004983 Ethanolamines AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives. Aminoethanols
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

G Danti, and S Pomari, and G Covi, and E Pedrolli, and G Zannini, and M Mattioli, and A Lechi
[Long-term therapy with atenolol and chlorthalidone in medium- and high-grade arterial hypertension].
April 1986, Giornale di clinica medica,
G Danti, and S Pomari, and G Covi, and E Pedrolli, and G Zannini, and M Mattioli, and A Lechi
Long-term treatment of hypertension with labetalol.
January 1980, Postgraduate medical journal,
G Danti, and S Pomari, and G Covi, and E Pedrolli, and G Zannini, and M Mattioli, and A Lechi
Long-term treatment of hypertension with labetalol.
April 1979, British journal of clinical pharmacology,
G Danti, and S Pomari, and G Covi, and E Pedrolli, and G Zannini, and M Mattioli, and A Lechi
Long-term treatment of hypertension with labetalol.
January 1979, British journal of clinical pharmacology,
G Danti, and S Pomari, and G Covi, and E Pedrolli, and G Zannini, and M Mattioli, and A Lechi
Labetalol in long-term treatment of hypertension.
August 1976, British journal of clinical pharmacology,
G Danti, and S Pomari, and G Covi, and E Pedrolli, and G Zannini, and M Mattioli, and A Lechi
Effects of long-term therapy with labetalol on lipoprotein metabolism in patients with mild hypertension.
January 1985, Acta medica Scandinavica,
G Danti, and S Pomari, and G Covi, and E Pedrolli, and G Zannini, and M Mattioli, and A Lechi
[Arterial hypertension. Factors favoring long-term compliance with therapy].
January 2007, Revue medicale suisse,
G Danti, and S Pomari, and G Covi, and E Pedrolli, and G Zannini, and M Mattioli, and A Lechi
Effects of long-term high-dose labetalol on blood pressure in patients with severe hypertension resistant to previous therapy.
January 1980, Postgraduate medical journal,
G Danti, and S Pomari, and G Covi, and E Pedrolli, and G Zannini, and M Mattioli, and A Lechi
Hemodynamic long-term effects of labetalol in essential hypertension.
January 1979, Acta medica Scandinavica. Supplementum,
G Danti, and S Pomari, and G Covi, and E Pedrolli, and G Zannini, and M Mattioli, and A Lechi
The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension.
January 1980, Postgraduate medical journal,
Copied contents to your clipboard!